Suppr超能文献

源自系链作用的半胱天冬酶-1抑制剂的结构分析

Structural analysis of caspase-1 inhibitors derived from Tethering.

作者信息

O'Brien Tom, Fahr Bruce T, Sopko Michelle M, Lam Joni W, Waal Nathan D, Raimundo Brian C, Purkey Hans E, Pham Phuongly, Romanowski Michael J

机构信息

Department of Biology, Sunesis Pharmaceuticals Inc., USA.

出版信息

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 May 1;61(Pt 5):451-8. doi: 10.1107/S1744309105010109. Epub 2005 Apr 9.

Abstract

Caspase-1 is a key endopeptidase responsible for the post-translational processing of the IL-1beta and IL-18 cytokines and small-molecule inhibitors that modulate the activity of this enzyme are predicted to be important therapeutic treatments for many inflammatory diseases. A fragment-assembly approach, accompanied by structural analysis, was employed to generate caspase-1 inhibitors. With the aid of Tethering with extenders (small molecules that bind to the active-site cysteine and contain a free thiol), two novel fragments that bound to the active site and made a disulfide bond with the extender were identified by mass spectrometry. Direct linking of each fragment to the extender generated submicromolar reversible inhibitors that significantly reduced secretion of IL-1beta but not IL-6 from human peripheral blood mononuclear cells. Thus, Tethering with extenders facilitated rapid identification and synthesis of caspase-1 inhibitors with cell-based activity and subsequent structural analyses provided insights into the enzyme's ability to accommodate different inhibitor-binding modes in the active site.

摘要

半胱天冬酶 -1是一种关键的内肽酶,负责白细胞介素 -1β和白细胞介素 -18细胞因子的翻译后加工,预计可调节该酶活性的小分子抑制剂将成为许多炎症性疾病的重要治疗方法。采用片段组装方法并结合结构分析来生成半胱天冬酶 -1抑制剂。借助延伸剂连接(与活性位点半胱氨酸结合并含有游离硫醇的小分子),通过质谱鉴定出两个与活性位点结合并与延伸剂形成二硫键的新型片段。将每个片段直接与延伸剂连接产生了亚微摩尔级的可逆抑制剂,这些抑制剂显著减少了人外周血单核细胞中白细胞介素 -1β的分泌,但不影响白细胞介素 -6的分泌。因此,延伸剂连接有助于快速鉴定和合成具有细胞活性的半胱天冬酶 -1抑制剂,随后的结构分析为该酶在活性位点容纳不同抑制剂结合模式的能力提供了见解。

相似文献

1
Structural analysis of caspase-1 inhibitors derived from Tethering.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 May 1;61(Pt 5):451-8. doi: 10.1107/S1744309105010109. Epub 2005 Apr 9.
2
In situ assembly of enzyme inhibitors using extended tethering.
Nat Biotechnol. 2003 Mar;21(3):308-14. doi: 10.1038/nbt786. Epub 2003 Feb 3.
4
Structure-based combinatorial library design: discovery of non-peptidic inhibitors of caspases 3 and 8.
J Comput Aided Mol Des. 2001 Dec;15(12):1105-17. doi: 10.1023/a:1015976725743.
5
Solid-phase synthesis of azidomethylene inhibitors targeting cysteine proteases.
Org Lett. 2008 May 15;10(10):1881-4. doi: 10.1021/ol800575z. Epub 2008 Apr 12.
6
Identification of specific tethered inhibitors for caspase-5.
Chem Biol Drug Des. 2012 Feb;79(2):209-15. doi: 10.1111/j.1747-0285.2011.01261.x. Epub 2011 Nov 28.
7
Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Biopolymers. 1999;51(1):109-18. doi: 10.1002/(SICI)1097-0282(1999)51:1<109::AID-BIP12>3.0.CO;2-S.
8
Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry.
Bioorg Med Chem Lett. 2008 Jul 15;18(14):3978-81. doi: 10.1016/j.bmcl.2008.06.011. Epub 2008 Jun 10.
9
Structure-based discovery of a novel non-peptidic small molecular inhibitor of caspase-3.
Bioorg Med Chem. 2008 May 1;16(9):4854-9. doi: 10.1016/j.bmc.2008.03.046. Epub 2008 Mar 21.
10
Irreversible caspase inhibitors: tools for studying apoptosis.
Methods. 1999 Apr;17(4):320-8. doi: 10.1006/meth.1999.0746.

引用本文的文献

1
Unveiling the Mechanistic Singularities of Caspases: A Computational Analysis of the Reaction Mechanism in Human Caspase-1.
ACS Catal. 2023 Mar 15;13(7):4348-4361. doi: 10.1021/acscatal.3c00037. eCollection 2023 Apr 7.
2
Small Molecule Active Site Directed Tools for Studying Human Caspases.
Chem Rev. 2015 Nov 25;115(22):12546-629. doi: 10.1021/acs.chemrev.5b00434. Epub 2015 Nov 9.
3
Therapeutic approaches to preventing cell death in Huntington disease.
Prog Neurobiol. 2012 Dec;99(3):262-80. doi: 10.1016/j.pneurobio.2012.08.004. Epub 2012 Aug 28.

本文引用的文献

1
Molecular mechanisms of caspase regulation during apoptosis.
Nat Rev Mol Cell Biol. 2004 Nov;5(11):897-907. doi: 10.1038/nrm1496.
2
Refinement of macromolecular structures by the maximum-likelihood method.
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55. doi: 10.1107/S0907444996012255.
4
Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly.
Curr Opin Chem Biol. 2004 Aug;8(4):399-406. doi: 10.1016/j.cbpa.2004.06.010.
5
Tethering: fragment-based drug discovery.
Annu Rev Biophys Biomol Struct. 2004;33:199-223. doi: 10.1146/annurev.biophys.33.110502.140409.
6
Prospects for caspase inhibitors.
Mini Rev Med Chem. 2004 Feb;4(2):153-65. doi: 10.2174/1389557043487448.
7
Identification of potent and novel small-molecule inhibitors of caspase-3.
Bioorg Med Chem Lett. 2003 Nov 3;13(21):3651-5. doi: 10.1016/j.bmcl.2003.08.024.
9
In situ assembly of enzyme inhibitors using extended tethering.
Nat Biotechnol. 2003 Mar;21(3):308-14. doi: 10.1038/nbt786. Epub 2003 Feb 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验